Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Busch

Showing results (151-160 of 216) with videos related to

Pageof 22
Sort By:
Transfusion|January 25, 2000
Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookbackM P Busch, L H Tobler, G Tegtmeier, et al.
Transfusion|June 1, 1997
A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor StudyJ J Korelitz, M P Busch, S H Kleinman, et al.
Transfusion|October 1, 1994
Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor StudyJ J Korelitz, A E Williams, M P Busch, et al.
Transfusion|July 21, 1999
Redefining the HIV-infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood-borne transmissionK K Murthy, D R Henrard, J W Eichberg, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Persistent immune complexes and abnormal CD4/CD8 ratios in HIV infectionS Roy, W J Morrow, C Christian, et al.
Transfusion|June 1, 1992
Comparative evaluation of supplemental hepatitis C virus antibody test systemsC S Evans, L Tobler, A Polito, et al.
Journal of Viral Hepatitis|July 24, 2008
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug usersM Zeremski, M A Shu, Q Brown, et al.
Transfusion|January 1, 1993
A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donorsM P Busch, L Tobler, S Quan, et al.
Genes and Immunity|November 13, 2004
Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infectionM K Elkins, E Vittinghoff, S E Baranzini, et al.
Vox Sanguinis|December 22, 2006
Antibodies to a novel antigen in acute hepatitis C virus infectionsL H Tobler, S L Stramer, D Y Chien, et al.
Pageof 22

Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
Transfusion|January 25, 2000
Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookbackM P Busch, L H Tobler, G Tegtmeier, et al.
Transfusion|June 1, 1997
A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor StudyJ J Korelitz, M P Busch, S H Kleinman, et al.
Transfusion|October 1, 1994
Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor StudyJ J Korelitz, A E Williams, M P Busch, et al.
Transfusion|July 21, 1999
Redefining the HIV-infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood-borne transmissionK K Murthy, D R Henrard, J W Eichberg, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Persistent immune complexes and abnormal CD4/CD8 ratios in HIV infectionS Roy, W J Morrow, C Christian, et al.
Transfusion|June 1, 1992
Comparative evaluation of supplemental hepatitis C virus antibody test systemsC S Evans, L Tobler, A Polito, et al.
Journal of Viral Hepatitis|July 24, 2008
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug usersM Zeremski, M A Shu, Q Brown, et al.
Transfusion|January 1, 1993
A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donorsM P Busch, L Tobler, S Quan, et al.
Genes and Immunity|November 13, 2004
Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infectionM K Elkins, E Vittinghoff, S E Baranzini, et al.
Vox Sanguinis|December 22, 2006
Antibodies to a novel antigen in acute hepatitis C virus infectionsL H Tobler, S L Stramer, D Y Chien, et al.
Pageof 22